|
Market Closed -
Nasdaq
01:00:00 14/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 24.60 USD | -5.53% |
|
-3.45% | +39.46% |
| 11-13 | Zai Lab Limited - Special Call | |
| 11-13 | Zai Lab Says Experimental Drug Reduced Activity of Protein Linked to Atopic Dermatitis by at Least 90% | MT |
Chart calendar Zai Lab Limited
Upcoming events on Zai Lab Limited
No events available
Past events on Zai Lab Limited
| 13/11/2026 | Information meeting | 17:00 |
| 05/11/2026 | Earnings release - Q3 2026 | |
| 05/11/2026 | Board of Directors Meeting | |
| 05/11/2026 | Earnings presentation | 17:00 |
| 23/10/2026 | Information meeting | 16:00 |
| 25/08/2026 | Board of Directors Meeting | |
| 06/08/2026 | Earnings presentation | 16:00 |
| 06/08/2026 | Earnings release - Q2 2026 | |
| 17/06/2026 | Annual General Meeting | 16:00 |
| 17/06/2026 | Présentation aux Actionnaires / Analystes | 16:00 |
| 07/05/2026 | Earnings presentation | 16:00 |
| 07/05/2026 | Earnings release - Q1 2026 | |
| 20/04/2026 | Information meeting | 16:30 |
| 28/03/2026 | Earnings release - Annual 2025 | |
| 27/03/2026 | Board of Directors Meeting | |
| 26/02/2026 | Earnings presentation | 17:00 |
| 26/02/2026 | Earnings release - Q4 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 267 269 -0.77% | 399 393 1.45% | 460 467 -1.56% | 439 | 538 | 711 |
|
EBITDA Million USD | Released Forecast Spread | -358 -342 -4.68% | -270 -304 11.03% | -214 -184 -16.51% | -268 | -237 | -171 |
|
EBIT Million USD | Released Forecast Spread | -367 -351 -4.32% | -282 -306 7.8% | -229 -200 -14.8% | -279 | -231 | -177 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -335 -354 5.6% | -257 -282 8.76% | -178 -166 -7.3% | -212 | -219 | -163 |
|
Net income Million USD | Released Forecast Spread | -335 -348 3.74% | -257 -280 8.02% | -176 -175 -0.56% | -213 | -218 | -140 |
|
EPS USD | Released Forecast Spread | -3,46 -3,47 0.18% | -2,60 -2,71 4.05% | -1,60 -1,68 4.69% | -1,87 | -2,13 | -1,17 |
| Announcement Date | 27/02/24 | 27/02/25 | 26/02/26 | - |
Quarterly results
| Fiscal Period | September | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 106 116 -8.09% | 110 125 -12.03% | 116 144 -19.23% | 128 123 4.02% | 99,6 108 -8.14% | 106 104 2.41% | 108 109 -0.44% | 103 | 113 | 118 | 125 | 136 |
|
EBITDA Million USD | Released Forecast Spread | -51,2 -28,4 -79.94% | -44,9 -39,3 -14.34% | -65,5 -45,2 -45.02% | -65,4 -54,5 -20.03% | -72,3 -65,7 -10.01% | -58,6 -64,4 8.99% | -68,7 | |||||
|
EBIT Million USD | Released Forecast Spread | -56,3 -59,8 5.84% | -54,9 -47,9 -14.69% | -48,8 -39,2 -24.42% | -69,4 -43,4 -60.08% | -69,4 -60,0 -15.63% | -76,5 -78,5 2.6% | -63,0 -67,2 6.23% | -69,9 | -55,8 | -54,4 | -52,2 | -45,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -48,4 -54,4 10.88% | -40,7 -46,7 12.79% | -36,0 -24,8 -45.01% | -53,3 -27,6 -93.42% | -49,6 -61,6 19.49% | -51,8 -80,7 35.76% | -48,0 -57,0 15.83% | -63,9 | -49,6 | -48,3 | -46,0 | -39,5 |
|
Net income Million USD | Released Forecast Spread | -48,4 -54,8 11.66% | -40,7 -45,7 10.78% | -36,0 -26,8 -34.02% | -50,4 -35,8 -40.78% | -51,0 -62,3 18.13% | -50,8 -76,8 33.81% | -46,1 -57,6 19.85% | -65,7 | -49,6 | -48,3 | -46,0 | -39,5 |
|
EPS USD | Released Forecast Spread | -0,45 -0,57 20.35% | -0,37 -0,42 11.9% | -0,33 -0,24 -37.5% | -0,46 -0,35 -31.67% | -0,46 -0,56 18.53% | -0,46 -0,69 33.54% | -0,41 -0,50 18.75% | -0,52 | -0,44 | -0,42 | -0,41 | -0,37 |
| Announcement Date | 08/05/25 | 07/08/25 | 06/11/25 | 26/02/26 | 07/05/26 | 06/08/26 | 05/11/26 | - | - | - | - | - |
| 16/11/2026 | Extraordinary General Meeting | 10:30 | |
| 16/11/2026 | Earnings presentation | 06:00 | |
| 16/11/2026 | Earnings presentation | 11:00 | |
| 16/11/2026 | Extraordinary General Meeting | 10:30 | |
| 16/11/2026 | Présentation aux Actionnaires / Analystes | 12:30 | |
| 16/11/2026 | Extraordinary General Meeting | 12:30 | |
| 17/11/2026 | Ex-dividend date - 0.2 CNY | 09:00 | |
| 17/11/2026 | Ex-dividend date - 0.1 CNY | 09:00 | |
| 19/11/2026 | Earnings presentation | 12:00 | |
| 20/11/2026 | Ex-dividend date - 0.94 USD | 09:00 |
Past sector events for Zai Lab Limited
| 13/11/2026 | Earnings presentation | 06:00 | |
| 13/11/2026 | Extraordinary General Meeting | 10:30 | |
| 12/11/2026 | Analyst/Investor Day | 18:00 | |
| 12/11/2026 | Earnings presentation | 17:00 | |
| 12/11/2026 | Earnings release - Q4 2026 | ||
| 12/11/2026 | Earnings presentation | 11:00 | |
| 12/11/2026 | Earnings presentation | 11:00 | |
| 12/11/2026 | Extraordinary General Meeting | 11:00 | |
| 11/11/2026 | Extraordinary General Meeting | 11:00 | |
| 10/11/2026 | Information meeting | 17:30 |
Quarterly revenue - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ZLAB Stock
- Calendar Zai Lab Limited
Select your edition
All financial news and data tailored to specific country editions
















